These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23225191)

  • 1. Prognostic factors and prevention of radioembolization-induced liver disease.
    Gil-Alzugaray B; Chopitea A; Iñarrairaegui M; Bilbao JI; Rodriguez-Fraile M; Rodriguez J; Benito A; Dominguez I; D'Avola D; Herrero JI; Quiroga J; Prieto J; Sangro B
    Hepatology; 2013 Mar; 57(3):1078-87. PubMed ID: 23225191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of repeated yttrium-90 radioembolization.
    Lam MG; Louie JD; Iagaru AH; Goris ML; Sze DY
    Cardiovasc Intervent Radiol; 2013 Oct; 36(5):1320-8. PubMed ID: 23354961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
    Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization.
    Gaba RC; Lewandowski RJ; Kulik LM; Riaz A; Ibrahim SM; Mulcahy MF; Ryu RK; Sato KT; Gates V; Abecassis MM; Omary RA; Baker TB; Salem R
    Ann Surg Oncol; 2009 Jun; 16(6):1587-96. PubMed ID: 19357924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Radioembolization-Induced Liver Disease and Liver Toxicity Following Repeat 90Y-Radioembolization: Outcomes at a Large Tertiary Care Center.
    Elsayed M; Ermentrout RM; Sethi I; Bercu ZL; Galt JR; Whitmore M; Brandon DC; Schuster DM; Kokabi N
    Clin Nucl Med; 2020 Feb; 45(2):100-104. PubMed ID: 31876805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
    Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R
    Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option.
    Saxena A; Bester L; Chua TC; Chu FC; Morris DL
    Ann Surg Oncol; 2010 Feb; 17(2):484-91. PubMed ID: 19876691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach.
    Seidensticker R; Seidensticker M; Damm R; Mohnike K; Schütte K; Malfertheiner P; Van Buskirk M; Pech M; Amthauer H; Ricke J
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1109-18. PubMed ID: 22037709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
    Camacho JC; Kokabi N; Xing M; Prajapati HJ; El-Rayes B; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of 90Y radioembolization in patients who have undergone previous external beam radiation therapy.
    Lam MG; Abdelmaksoud MH; Chang DT; Eclov NC; Chung MP; Koong AC; Louie JD; Sze DY
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):323-9. PubMed ID: 23849697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
    Coldwell D; Sangro B; Salem R; Wasan H; Kennedy A
    Am J Clin Oncol; 2012 Apr; 35(2):167-77. PubMed ID: 21127414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
    Salem R; Lewandowski RJ; Mulcahy MF; Riaz A; Ryu RK; Ibrahim S; Atassi B; Baker T; Gates V; Miller FH; Sato KT; Wang E; Gupta R; Benson AB; Newman SB; Omary RA; Abecassis M; Kulik L
    Gastroenterology; 2010 Jan; 138(1):52-64. PubMed ID: 19766639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Y-90 Radioembolization After Prior Major Hepatic Resection.
    Zimmermann M; Schulze-Hagen M; Liebl M; Pedersoli F; Goerg F; Ulmer TF; Heinzel A; Isfort P; Kuhl C; Bruners P
    Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1206-1212. PubMed ID: 28357572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver disease induced by radioembolization of liver tumors: description and possible risk factors.
    Sangro B; Gil-Alzugaray B; Rodriguez J; Sola I; Martinez-Cuesta A; Viudez A; Chopitea A; Iñarrairaegui M; Arbizu J; Bilbao JI
    Cancer; 2008 Apr; 112(7):1538-46. PubMed ID: 18260156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioembolization-induced liver disease: a systematic review.
    Braat MN; van Erpecum KJ; Zonnenberg BA; van den Bosch MA; Lam MG
    Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):144-152. PubMed ID: 27926660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
    Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
    Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma.
    Mosconi C; Cappelli A; Ascanio S; Pettinari I; Modestino F; Renzulli M; Galaverni MC; Cucchetti A; Gramenzi A; Pettinato C; Golfieri R
    Future Oncol; 2017 Jun; 13(15):1301-1310. PubMed ID: 28343412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report.
    Kennedy A; Coldwell D; Sangro B; Wasan H; Salem R
    Am J Clin Oncol; 2012 Feb; 35(1):81-90. PubMed ID: 20938320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients.
    Bester L; Meteling B; Pocock N; Pavlakis N; Chua TC; Saxena A; Morris DL
    J Vasc Interv Radiol; 2012 Jan; 23(1):96-105. PubMed ID: 22079516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.